Wonder-Erect Male Pills: No wonder they contain hidden drug ingredient vardenafil

Last Updated on

Image of Wonder-Erect Male Pills

Wonder-Erect Pills: The male dream?

January 21, 2016 –  This is a never ending story. The present notification by the The American Food and Drug Administration (FDA) is once more to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Generally, consumers should exercise caution before purchasing any product in the above categories.

Here, in this particular case, FDA is advising consumers not to purchase or use Wonder-Erect Male Pills, a product promoted and sold for sexual enhancement on various websites and possible in some retail stores. Of course, announced of being a 100% herbal supplement and all natural.

In dire contrast, FDA laboratory analysis confirmed that Wonder-Erect Male Pills contain vardenafil. Vardenafil is the active ingredient in the FDA-approved prescription drug Levitra, used to treat erectile dysfunction (ED). Vardenafil is a PDE5 inhibitor.  Besides as Levitra, it is sold under the trade names Staxyn in India and Vivanza in Italy.

This undeclared ingredient may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Men with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Overall, vardenafil comes with a variety of sometimes serious, including fatal, adverse effects.  Thus, as with other PDE5 inhibitors (e.g., Sildenafil (Viagra), Tadalafil (Cialis), etc.) common adverse drug reactions (side-effects) include nausea, abdominal pain, back pain, photosensitivity, abnormal vision, eye pain, facial edemahypotension, palpitation, tachycardiaarthralgiamyalgia, rash, itch, and priapism, a very painful emergency condition that can cause impotence if left untreated. Another, possibly serious, but rare, side-effect with vardenafil is heart attack, and possible deafness (sudden hearing loss) had be added in the past by the FDA to the drug labels of Vardenafil (Levitra) and other PDE5 inhibitors. Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

 Consumers and patients alike may please refer to the links below for more information on the topic:

Tags: , , , , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Leave a Reply

Optional: Social Subscribe/Login




avatar
  Subscribe  
Notify of
Classicintermark
Guest
Classicintermark

To, The Purchase Manager/Head. Dear Sir/Madam, I am a reputed Pharmaceutical Dropshipper from Mumbai. I represent Classicintermark and we have been engaged in Pharmaceutical Distribution internationally . We currently distribute products of all Indian Manufacturers as well as major reputed Foreign Manufacturers. We would be extremely privileged to establish a business relationship with you which would ensure the achievement of our common endeavours to succeed. We request you to provide us an opportunity to serve you and we shall make it our endeavour to live up to your expectations. Give us a trial order. We won’t let you down. Why… Read more »

deezer hookah ice hose
Guest

Thanks , I’ve recently been searching for info approximately this subject for a long time
and yours is the greatest I have came upon till now. However,
what in regards to the bottom line? Are you sure in regards to the source?

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • In-office gene therapy for wet age-related macular degeneration is coming October 11, 2019
    Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration (AMD) have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks. Researchers […]
  • Powerful new genomics method can be used to reveal the causes of rare genetic diseases October 11, 2019
    A team led by a scientist at Scripps Research has invented a new genomics technique for tracking down the causes of rare genetic diseases.
  • Jumping genes can cause rare developmental disorders in children October 11, 2019
    The largest study of its kind into childhood developmental disorders has discovered that jumping genes cause genetic changes in some patients with undiagnosed neurodevelopmental diseases. The research from the Wellcome Sanger Institute and its collaborators in the NHS Regional Genetics services enabled genetic diagnoses for three children with previously undiagnosed rare developmental diseases who were […]
  • New customized drug treatment bypasses a single child's unique mutation within a year of diagnosis October 10, 2019
    An unprecedented case at Boston Children's Hospital shows that it's possible to do something that's never been done before: identify a patient's unique mutation, design a customized drug to bypass it, manufacture and test the drug, and obtain permission from the Food and Drug Administration (FDA) to begin treating the patient—all in less than one […]
  • Multigene testing for all breast cancer patients cost-effective October 10, 2019
    (HealthDay)—Unselected, multigene testing for all patients with breast cancer would be cost-effective in the United Kingdom and the United States, according to a study published online Oct. 3 in JAMA Oncology.
Top